Future Medicine India – Regulations & Polices Regulations and Policies Archives | Future Medicine India

Regulations and Policies

Surrogacy Bill: Violators face up to 5 years jail term; 10 lakhs fine

The Lok Sabha, the lower house of the Indian parliament, has cleared The Surrogacy (Regulation) Bill, 2019, recently. The bill prohibits commercial surrogacy and allows “altruistic surrogacy” which does not involve monetary compensation to the surrogate mother apart from medical expenses and insurance coverage during the pregnancy. One of the major aims of the bill […]

Read More..

EMA & USFDA: On the same page?

EMA and the US Food and Drug Administration (FDA) are aligned in more than 90% of marketing authorisation decisions for new medicines, found a joint analysis by the top global drug regulatory agencies.   The EMA/FDA analysis compared decisions on 107 new medicine applications at the two agencies between 2014 and 2016. The study entitled […]



Even as Travancore-Cochin Medical Council (TCMC), the Kerala state medical council, has once again issued a circular asking the medical professionals in the state to prescribe medicines in generic names


Guidelines for nano drugs

The Department of Biotechnology (DBT) and Indian Society of Nano Medicine has come out with guidelines for evaluation of nanopharmaceuticals in India.


Loopholes in the law

In a significant development, Lok Sabha recently passed the much-awaited Surrogacy (Regulation) Bill 2016, which bans commercial surrogacy in the country


What keeps drug prices high

Information asymmetry and supplier-induced demand are significantly restricting consumer choice in Indian healthcare, according to a recent policy note issued by Competition Commision of India (CCI).


MCI in dire straits

Nearly two months after the Union Government promulgated an ordinance replacing the existing Executive Committee of the Medical Council of India (MCI) with a nominated board of governors, nobody is sure what is going to happen next.

Dr Sumit Ghoshal